|
name click to compare prices |
Acclarent, Animas, Aveeno | Band-Aid, Benadryl, Benecol | Carefree , Centocor, Clean & Clear, Conor Medsystems, Cougar Biotechnology | Dermabond | Evithrom | Fast Take | Immodium, Indigo Laser | Johnson , Johnson & Johnson , Johnson Healthflow | Listerine | Mammotome, McNeil Manufacturing, Monistat, Motrin, Mylanta | Neutrogena | O.B. , Omrix, Ortho Autovue, Ortho Biotech Products, Ortho Dermatological, Ortho-Clinical Diagnostics, Ortho-McNeil Pharmaceutical | Peptid AC | Reach, Regranex, Rembrandt, Rena Rowan, Risperdal | Serena, Shower & Shower, Silhouette, Splenda, S-Rom, Stayfree , Sterrad, Sudafed | Therakos, Theraseed, Thermachoice, Tibotec-Virco | Ultacision | Versapoint |
» Shop local, ethical and at the best price on Ethishop |
|
|
|
shareholder | country | % | source |
|
year | business source |
2006 | Johnson & Johnson is the world's sixth-largest pharmaceutical group. | Les Echos |
2006 | World's largest medical equipment maker. | Les Echos |
|
country | address & contact : production type incentive source |
China | PharmaValley, Shanghai : R&D Les Echos |
Hong-Kong | Johnson & Johnson (Hong Kong) Limited : |
Ireland | Johnson & Johnson (Ireland) Limited : |
Ireland | Impulse Dynamics (Ireland) Limited : |
Ireland | Johnson & Johnson International Financial Services Co : |
Ireland | Johnson & Johnson Vision Products (Ireland) Ltd : |
Pakistan | Johnson & Johnson Pakistan (Private) Limited : |
Switzerland | The R.W. Johnson Pharmaceutical Research Institute : |
|
year name | photo position; compensation source |
2006Weldon, William C | Chief Executive Officer; salary: 9,12 million US$; stock-options: 0,72 million US$;
|
2005Darreta, Robert J | Chief Financial Officer; salary: 1,87 million US$; stock-options: 2,79 million US$;
|
2005Weldon, William C | Chief Executive Officer; salary: 4,58 million US$; stock-options: 1,83 million US$;
|
1998Larsen, Ralph S | Chief Executive Officer; salary: 12,06 million US$; Forbes |
|
year | employees <> | social impact : country source |
2007 | 120500 -3600 | Internal restructuring: Johnson & Johnson cuts 3 to 4% of its workforce to save up to 1.6 billion dollars in 2008.: | L'Expansion |
1995 | | | Corporate Crime Reporter |
1989 | -102 | | Canadian Labour Congress |
|
year | employees <> | social impact : country source |
|
year | country : consequences source |
2005 | brand: Risperdal : Older patients with dementia who are given antipsychotic medicines are far more likely to die prematurely than those given placebos. Most died of heart-related problems like heart failure or infections like pneumonia (FDA) | New York Times |
1997 | : Cause la mort de 1,5 millions enfants chaque année | Unicef |
|
year | country : consequences source |
|
year | financial misdemeanor | sales | income | | | source |
2006 |
| 53,3 | 11,11 | |   | billion US$ | |
2005 |
Portugal’s Competition Authority has fined five drug companies a total of EUR 16 millions for operating a cartel. The companies, Johnson and Johnson, Abbott Laboratories, Bayer, Menarini Diagnosticos, Roche Holding AG, fixed prices during 36 bidding processes to supply 22 hospitals from November 2001 to January 2003. |
| | | |   | | |
2005 |
| 50,51 | 10,41 | |   | billion US$ | Les Echos |
2004 |
| 47,35 | 8,51 | |   | billion US$ | |
2003 |
| 41,86 | 7,2 | |   | billion US$ | |
2002 |
| 36,3 | 6,6 | |   | billion US$ | |
2002 |
allegations of false record-keeping at a J&J plant that makes an anemia drug linked to serious side effects. |
| | | |   | | CNN |
2001 |
| 33 | 5,67 | |   | billion US$ | |
2000 |
| 29,14 | 4,8 | |   | billion US$ | |
1999 |
| 27,47 | 4,17 | |   | billion US$ | |
1998 |
| 23,66 | 3,06 | |   | billion US$ | |
|
year | financial misdemeanor | sales | income | assets | buyback | source |
|
year | purpose : intermediary/lobby : institution source |
2004 | To prevent binding EU legislation on European Resources : ASSURE (The Association for the Sustainable Use and Recovery Of Resources in Europe) : : Commission Européen translate | ASSURRE |
2001 | Access to foreign market (through MAI, WTO, GATS), prevent binding environmental regulations : USCIB (US Council For International Business) : : US Government translate | USCIB |
2000 | Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translate | Washington Post |
2000 | Investment protection and market access (to Mexico and Canada through NAFTA), to Latin America (through FTAA). : Business Roundtable : : US government, senate, congress translate | Center for Responsive Politics |
2000 | Prevent binding environmental regulations (environmental protection through economic growth, self-regulation and free trade) : WBCSD (World Business Council for Sustainable Development) : : United Nations translate | Corporate Europe Observatory |
2000 | Prevent binding regulation, co- or self-regulation instead. : American Chamber of Commerce's EU Committee : : European Commission translate | Corporate Europe Observatory |
2000 | Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translate | EFPIA |
1999 | Market access and investment protection (through WTO, GATS), avoid social and environmental rules : ICC (International Chamber of Commerce) : : WTO, GATS translate | Corporate Europe Observatory |
1998 | Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 209 thousand US$ : US President, Congress, Senate translate | Center for Responsive Politics |
|
year | purpose : intermediary/lobby : institution source |
|
year | dubious practice : image source |
2006 | Deceptive advertising: Plainte collective pour publicité mensongère contre la marque de crème solaire Neutrogena aux Etats-Unis, accusée de faire croire à leurs utilisateurs qu'ils sont protégés contre les maladies de peau. Son étiquette est "clairement trompeuses" dans la mesure où elle fait croire que "la crème faitécran contre tous les méfaits des rayons solaires", alors qu'elle ne protège que contre les coups de soleil, a déclaré l'un des avocats. Les auteurs de la plainte demandent que des termes comme "écran total", "waterproof" ou toute autre déclaration prêtant à confusion disparaissent des étiquettes. Ils réclament aussi que le fabricant soit contraint de "restituer l'argent frauduleusement obtenu" en finançant une fondation pour la recherche sur les cancers de la peau.: | AFP |
2004 | Arguable partnership: Don pour les victimes du tsunami: 2000000 de dollars: value: Humanitaire; | AFP |
2002 | Disinformation: PR campaign with Fleishman-Hillard France: public relations: F | CB-News |
2001 | ad budget: 1227 million US$; | Advertising Age |
2000 | ad budget: 1232 million US$; | Advertising Age |
1998 | ad budget: 1177 million US$; | Advertising Age |
1997 | ad budget: 1272 million US$; | Advertising Age |
1996 | ad budget: 1406 million US$; | Advertising Age |
|
|
|